ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 251 filers reported holding ADMA BIOLOGICS INC in Q2 2024. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,183,997 | -23.8% | 463,685 | -55.0% | 0.04% | -10.3% |
| Q1 2024 | $6,807,524 | +552.2% | 1,031,443 | +346.6% | 0.04% | +457.1% |
| Q4 2023 | $1,043,808 | -3.1% | 230,931 | -23.2% | 0.01% | -12.5% |
| Q3 2023 | $1,076,737 | -10.8% | 300,764 | -8.1% | 0.01% | 0.0% |
| Q2 2023 | $1,207,452 | +159.1% | 327,223 | +132.4% | 0.01% | +166.7% |
| Q1 2023 | $465,992 | -1.7% | 140,783 | +15.3% | 0.00% | 0.0% |
| Q4 2022 | $473,868 | -18.4% | 122,131 | -61.5% | 0.00% | -40.0% |
| Q1 2022 | $581,000 | +119.2% | 317,542 | +69.1% | 0.01% | +66.7% |
| Q4 2021 | $265,000 | +165.0% | 187,800 | +200.6% | 0.00% | +200.0% |
| Q2 2021 | $100,000 | +31.6% | 62,484 | +44.3% | 0.00% | 0.0% |
| Q1 2021 | $76,000 | +322.2% | 43,300 | +610.3% | 0.00% | – |
| Q1 2020 | $18,000 | – | 6,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |